Endo Health to acquire Paladin Labs for $1.6B

|About: Endo International plc (ENDP)|By:, SA News Editor

Endo Health Solutions (ENDP) has agreed to acquire Canadian peer Paladin Labs (PLDLF) for about $1.6B in a cash and stock deal that will expand Endo's presence in emerging markets as well as in Canada.

Endo will pay C$77 ($73.98) a share, representing a premium of over 20% to Paladin's close yesterday.

Endo expects the deal to be immediately accretive to its 2014 adjusted EPS.

Endo's shares are +2.3%. (Endo's Q3 earnings). (PR)